RecruitingNCT06274671

Glymphatic MRI in Clinically Isolated Syndrome

A Pilot Study to Investigate Glymphatic System Alterations in Vivo in Patients With Clinically Isolated Syndrome, Using Magnetic Resonance Imaging


Sponsor

University of Exeter

Enrollment

30 participants

Start Date

May 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The brain possesses a system to get rid of unwanted substances, named Glymphatic System (GS). When this system is faulty, these accumulate, there is local inflammation, and progressive death of the cells. This occurs in neurological diseases including Parkinson's, or Alzheimer's. Inflammation and progressive death of the cells are also present in another neurological disorder, named Multiple Sclerosis (MS). Doctors think that GS dysfunction plays a role in MS too. In this research therefore, the aim is to study whether it drives inflammation, and disease progression in MS patients. The researchers have developed a new way to find signs of alteration of the GS using a scan named Magnetic Resonance Imaging (MRI) and will use it in a pilot study on patients with a condition named Clinically Isolated Syndrome (CIS), which often represents the very beginning of MS. It would therefore be demonstrated that the GS is a new mechanism of disease in CIS, which may associate with the symptoms, or the alterations in the levels of some substances in the blood suggestive of brain cells damage. Should this study be successful, this would provide preliminary evidence to perform a larger research study to assess if GS dysfunction drives the progression of MS.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using a special type of MRI to examine the brain's waste-clearance system (called the glymphatic system) in people who have recently experienced a first episode that may indicate MS (called Clinically Isolated Syndrome). Researchers want to understand if impaired brain fluid drainage plays a role in MS progression. **You may be eligible if...** - You are 18 years or older - You have recently been diagnosed with Clinically Isolated Syndrome (CIS) or MS at first presentation - You have not taken steroids, IVIg, or plasma exchange in the past 30 days - You have adequate vision and hearing to complete study tasks - You are in generally good health - If taking MS immune-modifying medication, you have been on a stable dose for at least 30 days **You may NOT be eligible if...** - You already have a confirmed diagnosis of definite Multiple Sclerosis (by 2017 McDonald Criteria) - Your CIS is limited to spinal cord only (transverse myelitis) - You have a significant psychiatric condition that would interfere with the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMagnetic Resonance Imaging

A Magnetic Resonance Imaging (duration: about 60 minutes) with research sequences for the visualization of alterations of the glymphatic system.


Locations(2)

University of Exeter

Exeter, Exeter, United Kingdom

Royal Devon University Healthcare NHS Foundation Trust

Exeter, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06274671


Related Trials